Literature DB >> 14062721

MITOGENIC EFFECT OF RABIES VACCINE ON CULTURES OF LYMPHOCYTES IN DISEASES OF THE NERVOUS SYSTEM.

N HASHEM, M L BARR.   

Abstract

Keywords:  ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; CELL DIVISION; ENCEPHALITIS, POST-VACCINAL; LUPUS ERYTHEMATOSUS, DISCOID; LYMPHOCYTES; MONGOLISM; MULTIPLE SCLEROSIS; NEUROLOGY; POLYRADICULITIS; RABIES VACCINE; THYROIDITIS

Mesh：

Substances：

Year:  1963        PMID： 14062721     DOI： 10.1016/s0140-6736(63)90004-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  Rabies virus vaccine as an immune adjuvant against cancers and glioblastoma: new studies may resurrect a neglected potential.

Authors:  M A Altinoz; S Guloksuz; I Elmaci
Journal:  Clin Transl Oncol       Date:  2017-01-16       Impact factor: 3.405

Review 2.  Immunopathological comparisons between experimental autoimmune encephalomyelitis and multiple sclerosis.

Authors:  I R Mackay; P R Carnegie; A S Coates
Journal:  Clin Exp Immunol       Date:  1973-12       Impact factor: 4.330

3.  [Lymphocyte transformation in multiple sclerosis. Demonstration of cell sensitivity to basic myelin protein (author's transl)].

Authors:  E Frick; H Stickl; K H Zinn
Journal:  Klin Wochenschr       Date:  1974-03-01

4.  [On viral etiology of multiple sclerosis. Cell specific studies with Lyssa virus].

Authors:  E Frick; H Stickl
Journal:  Klin Wochenschr       Date:  1967-12-15

5.  Toxicity of motor neurone disease serum for myelin in tissue culture.

Authors:  E J Field; D Hughes
Journal:  Br Med J       Date:  1965-12-11

6.  Myelotoxicity of serum and spinal fluid in multiple sclerosis: a critical assessment.

Authors:  D Hughes; E J Field
Journal:  Clin Exp Immunol       Date:  1967-05       Impact factor: 4.330

7.  THE STIMULATION OF DNA SYNTHESIS IN CULTURES OF RABBIT LYMPH NODE AND SPLEEN CELL SUSPENSIONS BY HOMOLOGOUS CELLS.

Authors:  N D CHAPMAN; R W DUTTON
Journal:  J Exp Med       Date:  1965-01-01       Impact factor: 14.307
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.